MDGL Financials
Madrigal Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$538.71
Market Cap
$11.56B
P/E Ratio
-24.6
EPS
$-12.92
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$180.13M
Gross Profit
-
Operating Income
-
Net Income
$-465.89M
EPS (Diluted)
$-21.90
Balance Sheet Highlights
Total Assets
$1.04B
Total Liabilities
$287.86M
Shareholders Equity
-
Cash & Equivalents
$100.02M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-455.57M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-39.7%
Net Margin
-39.0%
ROE
-41.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MDGL revenue?
MDGL's most recent quarterly revenue was $180.13M. Annual revenue can be calculated by summing the four most recent quarters.
Is MDGL profitable?
MDGL reported a loss of $465.89M in the most recent quarter. The net profit margin is -39.0%.
What is MDGL market cap?
MDGL has a market capitalization of $11.56B, making it a large-cap stock.
Does MDGL have debt?
View MDGL's balance sheet for debt information.
What is MDGL cash flow?
Cash flow data is available in the full financial statements.